ArticlePatient preference and adherence2016

Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations.

Lulu K Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.